List of insiders holdings for 23andMe Holding Co.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Wojcicki Anne ABeeC 2.0 LLC Chief Executive Officer 10% Owner | 2024-04-17 18:21:31 | 108,594,201 0 | 108,594,201 | Form 13D |
| GSK PLC 10% Owner | 2024-02-09 16:18:35 | 39,660,487 0 | 39,660,487 | Form 13D |
| SC US (TTGP) LTD. SC Global Growth II Management L.P. SEQUOIA CAPITAL GLOBAL GROWTH FUND II L.P. SEQUOIA CAPITAL GLOBAL GROWTH II PRINCIPALS FUND L.P. LEONE DOUGLAS M BOTHA ROELOF Sequoia Grove Manager LLC Sequoia Grove II LLC 10% Owner | 2021-06-30 17:21:03 | 14,184,390 0 | 14,184,390 | Form 13G |
| SC US (TTGP) LTD. SC U.S. Growth VII Management L.P. SEQUOIA CAPITAL U.S. GROWTH FUND VII L.P. SEQUOIA CAPITAL U.S. GROWTH VII PRINCIPALS FUND L.P. SCGF III MANAGEMENT LLC SEQUOIA CAPITAL GROWTH FUND III SC U.S. Growth VIII Management L.P. Sequoia Capital U.S. Growth Fund VIII L.P. 10% Owner | 2021-06-30 17:21:03 | 14,184,390 0 | 14,184,390 | Form 13G |
| VG Acquisition Sponsor LLC Corvina Holdings LTD Virgin Group Holdings LTD Branson Sir Richard 10% Owner | 2021-02-16 13:09:21 | 12,623,750 0 | 12,623,750 | Form 13G |
| Wojcicki Anne Chief Executive Officer 10% Owner | 2023-09-19 16:15:27 | 9,527,115 0 | 9,527,115 | Form 4 |
| Lovell Evan Director | 2022-08-11 16:22:12 | 2,445,636 0 | 2,445,636 | Form 4 |
| Johnson Paul D VP, General Manager-Consumer | 2022-02-11 16:32:12 | 1,783,721 0 | 1,783,721 | Form 4 |
| HIBBS KATHY L Chief Administrative Officer | 2024-04-19 16:20:24 | 1,290,866 0 | 1,290,866 | Form 4 |
| Selsavage Joseph Anthony Interim CFO | 2024-02-21 16:35:29 | 1,273,659 0 | 1,273,659 | Form 4 |
| Richards William G Head of Therapeutics Discovery | 2024-02-21 16:36:48 | 646,540 0 | 646,540 | Form 4 |
| Lemon Steven Vice President, Engineering | 2022-02-11 16:27:36 | 584,650 0 | 584,650 | Form 4 |
| Keim Tracy VP, Consumer Marketing & Brand | 2022-02-11 16:31:12 | 399,877 0 | 399,877 | Form 4 |
| MONTGOMERY RICE VALERIE MD Director | 2023-09-08 16:56:26 | 339,544 0 | 339,544 | Form 4 |
| Hernandez Sandra R MD Director | 2023-09-08 16:57:41 | 337,549 0 | 337,549 | Form 4 |
| BOTHA ROELOF Director 10% Owner | 2023-09-08 16:53:38 | 193,379 110,561 | 303,940 | Form 4 |
| Chung Patrick S Director | 2023-09-08 16:54:51 | 301,421 0 | 301,421 | Form 4 |
| Taylor Peter J. Director | 2023-09-08 16:52:54 | 265,217 0 | 265,217 | Form 4 |
| Mohan Neal Director | 2023-09-08 16:55:42 | 245,806 0 | 245,806 | Form 4 |
| SCHELLER RICHARD H Director | 2023-09-08 16:57:09 | 237,476 0 | 237,476 | Form 4 |
| Kohler Frederick Mark Vice President, People | 2022-02-11 16:30:23 | 228,502 0 | 228,502 | Form 4 |
| Hillan Kenneth J. Chief Therapeutics Officer | 2023-06-07 16:20:51 | 221,876 0 | 221,876 | Form 4 |
| Schoch Steven J Chief Financial Officer | 2022-08-22 18:12:54 | 211,663 0 | 211,663 | Form 4 |
| Lockhart James B. III Director | 2020-12-10 20:34:29 | 130,000 0 | 130,000 | Form 4 |
| BROWN DOUGLAS R Director | 2020-12-10 20:33:51 | 100,000 0 | 100,000 | Form 4 |
| Briggs Teresa Director | 2020-12-10 20:35:31 | 80,000 0 | 80,000 | Form 4 |
| Bayliss Joshua Chief Executive Officer | 2020-12-10 20:29:50 | 100 0 | 100 | Form 4 |